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Radiation-induced GI toxicity is the primary dose limitation 
compromising therapy in cancer patients treated with radiation 
therapy. GUCY2C is the intestinal receptor for diarrheagenic bacterial 
enterotoxins and the endogenous paracrine hormones guanylin and 
uroguanylin. Following genomic insult, cyclic (c)GMP produced by 
ligand activation of GUCY2C enhances DNA damage sensing and 
repair in intestinal cells. Here, we show that the GUCY2C-cGMP axis 
mediates p53-dependent radioprotection of intestinal epithelial cells.
Materials/Methods
Following total body irradiation (TBI) of Gucy2C+/+ (wild type; n=3) 
and Gucy2C-/- (knockout; n=3) mice with 0, 5 and 10 Gy, intestines 
were formalin-fixed. Cell proliferation, apoptosis and DNA double 
strand breaks were quantified by immunohistochemistry using 
antibodies to Ki-67, cleaved caspase 3 and γ-H2AX, respectively. 
Gucy2C+/+ (n=29) and Gucy2C-/- (n=38) mice were exposed to 
13-18Gy TBI inducing lethal GI toxicity and survival followed up to 
10d. In vitro, HCT116 (p53 wild type) and HCT116p53-/- (p53 null) 
human colon cells were treated with cGMP for 3 d, followed by 10, 
30 and 50 Gy of ionizing radiation (IR).
Results
Gucy2C-/- mice exhibited accelerated death reflecting TBI-induced GI 
toxicity compared to Gucy2C+/+ mice (median survival: 7 d, Gucy2C+/+ 
mice; 5 d, Gucy2C-/- mice). The hazard ratio for death in Gucy2C-/- 
mice was 2.17 (95% confidence interval: 1.17 - 4.01, p = 0.0133 by 
the log-rank test). Reduced survival in Gucy2C-/- mice was associated 
with a 28% increase in crypt cell apoptosis (p = 0.09). Conversely, 
HCT116 cells preconditioned with cGMP resisted IR-induced cell 
death (12% cell death in cGMP-treated cells vs. 6% in control cells 
at 20 Gy; 17% vs. 10% at 40 Gy; 47.5% vs. 8% at 80 Gy). Protection 
by cGMP preconditioning was p53 dependent, and cGMP did not 
reduce IR-induced cell death in HCT116p53-/- cells (21.5% cell death 
in cGMP-treated cells vs. 25% in control cells at 20 Gy; 26% vs.19% 
at 40 Gy).
Conclusion
Eliminating the GUCY2C-cGMP axis increased radiation-induced 
intestinal DNA damage, crypt cell apoptosis, and lethal GI toxicity 
in Gucy2C-/-, compared to Gucy2+/+, mice. Conversely, GUCY2C 
downstream signaling in human colon cells in vitro attenuated 
radiation-induced cell death in a p53-dependent fashion. These 
observations suggest that the GUCY2C-cGMP axis maintains 
genomic integrity by amplifying DNA damage sensing and repair 
in the intestine following exposure to IR, protecting against lethal 
radiation-induced GI toxicity. They underscore the potential of oral 
administration of GUCY2C ligands for targeted radioprotection of 
intestinal epithelia to prevent IR-induced GI toxicity to improve the 
management of cancer therapy.
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